265 related articles for article (PubMed ID: 20562589)
21. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
23. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
Henry LR; Goldberg M; Scott W; Konski A; Meropol NJ; Freedman G; Weiner LM; Watts P; Beard M; McLaughlin S; Cheng JD
Ann Surg Oncol; 2006 Feb; 13(2):214-20. PubMed ID: 16418887
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial.
Dipetrillo T; Suntharalingam M; Ng T; Fontaine J; Horiba N; Oldenburg N; Perez K; Birnbaum A; Battafarano R; Burrows W; Safran H
Am J Clin Oncol; 2012 Feb; 35(1):64-7. PubMed ID: 21297434
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
26. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
[TBL] [Abstract][Full Text] [Related]
27. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
Forastiere AA; Heitmiller RF; Lee DJ; Zahurak M; Abrams R; Kleinberg L; Watkins S; Yeo CJ; Lillemoe KD; Sitzmann JV; Sharfman W
Cancer J Sci Am; 1997; 3(3):144-52. PubMed ID: 9161779
[TBL] [Abstract][Full Text] [Related]
28. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
[TBL] [Abstract][Full Text] [Related]
30. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
31. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
32. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
[TBL] [Abstract][Full Text] [Related]
33. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy.
Shimoyama S; Aoki F; Kojima J; Kaminishi M
Hepatogastroenterology; 1999; 46(28):2409-13. PubMed ID: 10522007
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
[TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
36. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
37. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
[TBL] [Abstract][Full Text] [Related]
38. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
Orditura M; Galizia G; Napolitano V; Martinelli E; Pacelli R; Lieto E; Aurilio G; Vecchione L; Morgillo F; Catalano G; Ciardiello F; Del Genio A; Di Martino N; De Vita F
Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
[TBL] [Abstract][Full Text] [Related]
39. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.
Wright CD; Wain JC; Lynch TJ; Choi NC; Grossbard ML; Carey RW; Moncure AC; Grillo HC; Mathisen DJ
J Thorac Cardiovasc Surg; 1997 Nov; 114(5):811-5; discussion 816. PubMed ID: 9375611
[TBL] [Abstract][Full Text] [Related]
40. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
